SCHEMBL8782847

SCHEMBL8782847

CC(CN(O)C(N)=O)NC(=O)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.65
LMNA P02545 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
ALOX5 P09917 5/20 0.53
HDAC8 Q9BY41 1/20 0.51
NPC1 O15118 2/20 0.46
MEN1 O00255 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
AKR1C3 P42330 1/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
GCK P35557 1/20 0.45
PTGES O14684 1/20 0.45
PKM P14618 1/20 0.44
F2 P00734 1/20 0.44
F7 P08709 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8782837 1.00 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8
SCHEMBL9484229 0.85 ALDH1A1 (0.49) ALDH1A1LMNASMN1; SMN2ALOX5NPC1
SCHEMBL8942682 0.84 SMN1; SMN2 (0.53) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8
SCHEMBL8783528 0.82 KDM4E (0.57) ALDH1A1LMNASMN1; SMN2ALOX5MEN1
SCHEMBL8783536 0.82 KDM4E (0.57) ALDH1A1LMNASMN1; SMN2ALOX5MEN1
SCHEMBL8942436 0.80 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8
SCHEMBL8248607 0.79 ALDH1A1 (0.72) ALDH1A1LMNASMN1; SMN2HDAC8NPC1
SCHEMBL8782857 0.79 HDAC8 (0.57) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8
SCHEMBL8783449 0.78 ALOX5 (0.57) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8
SCHEMBL8783294 0.77 MEN1 (0.57) ALDH1A1LMNASMN1; SMN2ALOX5HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0595995-B1 ARYLAMIDOALKYL- AND ARYLAMINOALKYL-N-HYDROXYUREA COMPOUNDS AND -N-HYDROXYFORMAMIDE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1997-01-15 EP disclosed
US-5514702-A Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity ABBOTT LABORATORIES (US) 1996-05-07 US disclosed
EP-0595995-A4 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1994-08-24 EP disclosed
EP-0595995-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY. ABBOTT LAB (US) 1994-05-11 EP disclosed
US-5214204-A Inhibitors of biosynthesis of leukotrienes ABBOTT LABORATORIES (US) 1993-05-25 US disclosed
WO-1993002037-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1993-02-04 WO disclosed